Banner Life Sciences

Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees

Banner Life Sciences is a privately held clinical-stage pharmaceutical company focused on developing specialty medications that address unmet medical needs. With a history rooted in formulation expertise and proprietary technologies, the company seeks to advance treatments for conditions where new therapeutic options are scarce, notably in the area of relapsing multiple sclerosis (MS). Based in High Point, North Carolina, Banner Life Sciences operates within the pharmaceutical manufacturing sector and maintains a presence as a smaller, privately held entity dedicated to specialized drug development.

The company targets healthcare providers and patients affected by MS, aiming to improve disease management through its product portfolio. A notable development in its recent history is the launch of BAFIERTAM, a novel fumarate for adults with relapsing forms of MS, signaling its focus on bringing clinically relevant therapies to the market. In 2025, Banner Life Sciences underwent an acquisition by Cycle Pharmaceuticals, reflecting a change in ownership while continuing to pursue its clinical-stage objectives within the US market.

Sign up for free to view info

Email Format Employee directory